China Resources Pharmaceutical Group Ltd. (HK:3320) has released an update.
KPC, partially owned by China Resources Pharmaceutical Group Ltd., released its unaudited financial results for the first half of 2024, showing a total asset increase of 5.15%, a slight net profit rise of 2.74% for shareholders, and a significant improvement in net cash flow from operating activities by 146.75%. However, revenue saw a decline of 5.73% compared to the previous year. Investors are advised to exercise caution and not solely rely on these results when trading in the company’s securities.
For further insights into HK:3320 stock, check out TipRanks’ Stock Analysis page.
